The WACC of Europlasma SA (ALEUP.PA) is 17.7%.
Range | Selected | |
Cost of equity | 5.30% - 9.00% | 7.15% |
Tax rate | 0.90% - 1.80% | 1.35% |
Cost of debt | 7.00% - 34.00% | 20.50% |
WACC | 6.6% - 28.8% | 17.7% |
Category | Low | High |
Long-term bond rate | 3.0% | 3.5% |
Equity market risk premium | 5.8% | 6.8% |
Adjusted beta | 0.05 | 0.44 |
Additional risk adjustments | 2.0% | 2.5% |
Cost of equity | 5.30% | 9.00% |
Tax rate | 0.90% | 1.80% |
Debt/Equity ratio | 4.36 | 4.36 |
Cost of debt | 7.00% | 34.00% |
After-tax WACC | 6.6% | 28.8% |
Selected WACC | 17.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for ALEUP.PA:
cost_of_equity (7.15%) = risk_free_rate (3.25%) + equity_risk_premium (6.30%) * adjusted_beta (0.05) + risk_adjustments (2.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.